Format

Send to

Choose Destination
Pathologe. 2018 Feb;39(1):11-17. doi: 10.1007/s00292-017-0407-5.

[Updates on tumours of the salivary glands : 2017 WHO classification].

[Article in German]

Author information

1
Labor für Dermatohistologie und Oralpathologie, Bayerstr. 69, 80335, München, Deutschland. Ihrler@dermpath-muenchen.de.
2
Pathologisches Institut, Ludwig-Maximilians-Universität, München, Deutschland. Ihrler@dermpath-muenchen.de.
3
Klinik für Hals‑, Nasen- und Ohrenheilkunde, Universitätsklinikum Jena, Jena, Deutschland.
4
Labor für Dermatohistologie und Oralpathologie, Bayerstr. 69, 80335, München, Deutschland.
5
Institut für Pathologie, Technische Universität München, München, Deutschland.

Abstract

In the new 2017 WHO classification, a reduction of the high number of entities of salivary carcinomas was implemented. There is only one new carcinoma entity: secretory carcinoma. There is a slight increase of reactive and benign entities by the inclusion of rare and well-established, but so far not included, lesions. Furthermore, there are some conceptual changes and pure changes in terminology. The impact of molecular findings is increasing and is so far restricted to diagnostic aspects.

KEYWORDS:

Carcinoma; Molecular pathology; Pleomorphic adenoma; Salivary gland neoplasms; World Health Organization

PMID:
29372306
DOI:
10.1007/s00292-017-0407-5

Supplemental Content

Full text links

Icon for Springer
Loading ...
Support Center